News
Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...
A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...
After three long months, on Aug. 18, Nesbit's Lanes held a celebration marking its grand reopening. Now, a fundraiser for ...
This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope ...
Robin Leaper lost her voice to ALS. Artificial Intelligence has given her back the ability to speak with her own voice.
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS ...
• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.
Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Amyotrophic Lateral Sclerosis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The amyotrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results